← FDA Drug Approvals (Drugs@FDA)

NDA212205

NDA · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2025-03-13

Drug application

FDA Application #

NDA212205

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

CIPLA LIMITED

First approval

2025-03-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown